Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases
- PMID: 19077110
- DOI: 10.1111/j.1365-2990.2008.01005.x
Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases
Abstract
The causes of most neurological disorders are not fully understood. Inflammation and blood-brain barrier dysfunction appear to play major roles in the pathology of these diseases. Inflammatory insults that occur during brain development may have widespread effects later in life for a spectrum of neurological disorders. In this review, a new hypothesis suggesting a mechanistic link between inflammation and blood-brain barrier function (integrity), which is universally important in both neurodevelopmental and neurodegenerative diseases, is proposed. The role of inflammation and the blood-brain barrier will be discussed in cerebral palsy, schizophrenia, Parkinson's disease, Alzheimer's disease and multiple sclerosis, conditions where both inflammation and blood-brain barrier dysfunction occur either during initiation and/or progression of the disease. We suggest that breakdown of normal blood-brain barrier function resulting in a short-lasting influx of blood-born molecules, in particular plasma proteins, may cause local damage, such as reduction of brain white matter observed in some newborn babies, but may also be the mechanism behind some neurodegenerative diseases related to underlying brain damage and long-term changes in barrier properties.
Similar articles
-
Effect of minocycline on inflammation-induced damage to the blood-brain barrier and white matter during development.Eur J Neurosci. 2007 Dec;26(12):3465-74. doi: 10.1111/j.1460-9568.2007.05973.x. Eur J Neurosci. 2007. PMID: 18088277
-
Factors involved in inflammation-induced developmental white matter damage.Neurosci Lett. 2009 Feb 27;451(3):232-6. doi: 10.1016/j.neulet.2009.01.021. Epub 2009 Jan 13. Neurosci Lett. 2009. PMID: 19152829
-
The blood-brain barrier in health and chronic neurodegenerative disorders.Neuron. 2008 Jan 24;57(2):178-201. doi: 10.1016/j.neuron.2008.01.003. Neuron. 2008. PMID: 18215617 Review.
-
Nitric oxide and neurological disorders.Mol Aspects Med. 2005 Feb-Apr;26(1-2):67-96. doi: 10.1016/j.mam.2004.09.004. Epub 2005 Jan 24. Mol Aspects Med. 2005. PMID: 15722115 Review.
-
[Does acidosis in brain play a role in Alzheimer's disease?].Neuropsychiatr. 2009;23(3):187-92. Neuropsychiatr. 2009. PMID: 19703385 German.
Cited by
-
Targeting neuro-inflammatory cytokines and oxidative stress by minocycline attenuates quinolinic-acid-induced Huntington's disease-like symptoms in rats.Neurotox Res. 2012 Nov;22(4):310-20. doi: 10.1007/s12640-012-9315-x. Epub 2012 Mar 6. Neurotox Res. 2012. PMID: 22392362
-
Lipopolysaccharide-induced blood brain barrier permeability is enhanced by alpha-synuclein expression.Neurosci Lett. 2013 Sep 13;551:23-7. doi: 10.1016/j.neulet.2013.06.058. Epub 2013 Jul 19. Neurosci Lett. 2013. PMID: 23876253 Free PMC article.
-
Immunology and oxidative stress in multiple sclerosis: clinical and basic approach.Clin Dev Immunol. 2013;2013:708659. doi: 10.1155/2013/708659. Epub 2013 Sep 24. Clin Dev Immunol. 2013. PMID: 24174971 Free PMC article. Review.
-
Breakdown of the Paracellular Tight and Adherens Junctions in the Gut and Blood Brain Barrier and Damage to the Vascular Barrier in Patients with Deficit Schizophrenia.Neurotox Res. 2019 Aug;36(2):306-322. doi: 10.1007/s12640-019-00054-6. Epub 2019 May 10. Neurotox Res. 2019. PMID: 31077000
-
Targeting nicotinic receptors for Parkinson's disease therapy.CNS Neurol Disord Drug Targets. 2011 Sep 1;10(6):651-8. doi: 10.2174/187152711797247849. CNS Neurol Disord Drug Targets. 2011. PMID: 21838678 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical